Observational studyAntimicrobial agents and chemotherapy2022

Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.

Fumiya Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.